Abstract: Two simple, rapid and sensitive spectrophotometric methods were developed for the determination of Fluorometholone in pharmaceutical formulations in methanol (Method A) and Octane sulfonic acid buffer (pH 3.0) (Method B). Beer's law was obeyed over the concentration range 0.1-80 μg/mL in both methods. The linear regression equations were found to be y = 0.040x + 0.005 and y = 0.040x -0.013 in Method A and B respectively. The % RSD was found to be 0.76 and 0.97 in Method A as well as 0.58 and 0.49 in Method B for intra-day and inter-day precision studies. The % RSD in accuracy studies was also found to be less than 2.0. The proposed methods are simple and suitable for the determination of Fluorometholone in pharmaceutical formulations. No interferences were observed from the excipients in the formulations. The methods were validated according to ICH guidelines.
Introduction
Fluorometholone is a corticosteroid, most often used after laser-based refractive surgery. Fluorometholone, chemically 9α-fluoro-11b,17α-dihydroxy-6α-methylpregna-1, 4-diene-3,20-dione is a corticosteroid employed for its glucocorticoid activity 1 . The drug is formulated as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders [2] [3] . However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated 4 that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid 5 response elements in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes.
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Chem Sci Trans., 2014, 3(1), [445] [446] [447] [448] [449] A survey of the literature revealed that the methods reported for the determination of fluorometholone include spectrophotometric techniques [6] [7] , LC-MS [8] [9] [10] and TLCspectrodensitometric 11 methods. The authors have developed two simple validated spectrophotometric methods for the determination of Fluorometholone in bulk and pharmaceutical formulations as per ICH guidelines 12 .
Figure 1. Chemical structure of fluorometholone
Experimental
A double beam UV-Vis spectrophotometer (UV-1800, Shimadzu, Japan) connected to computer loaded with spectra manager software UV Probe was employed with spectral bandwidth of 1nm and wavelength accuracy of ±0.3 nm with a pair of 10 mm matched quartz cells. All weights were taken on electronic balance (Denver, Germany). For scanning, the wavelength range selected was from 400 nm to 200 nm with medium scanning speed. All experiments were performed at room temperature (25±1) °C.
Reagents and chemicals
Fluorometholone standard (purity ≥ 98.0%) was obtained from Eisai Pharmaceuticals (India). Fluorometholone is available commercially with brand names FLAREX and FLUMETHOLON (containing 0.1% of the drug content) respectively and were procured from the local market.
Preparation of stock and sample solution
The standard solution of fluorometholone was prepared by dissolving accurately about 25 mg of the Fluorometholone with methanol in a 25 mL volumetric flask.
Preparation of 0.02M Octane1-sulfonic acid buffer (pH 3.0)
4.35 g of Octane 1-sulfonic acid was dissolved in 1000 mL of water and pH was adjusted to 3.0 with o-phosphoric acid. The stock solution was further diluted with methanol and Octane sulfonic acid buffer (pH 3.0) for method A and method B (0.1-80 μg/mL) to obtain required sample solutions.
Procedure
Method A
The drug solution was scanned (200-400 nm) against reagent blank (methanol) and the absorption spectrum (Figure 2 ) was recorded. The absorption maximum (λ max ) was observed at 240 nm. A series of solutions (0.1-80 μg/mL) were prepared and the absorbance of these solutions was recorded at that λ max . A graph was plotted by taking the concentration of the solutions on the x-axis and the corresponding absorbance values on the y-axis (Figure 3 ).
Method B
The drug solution was scanned (200-400 nm) against reagent blank (Octane 1-sulfonic acid buffer pH 3.0) and the absorption spectrum was recorded (Figure 4) . A series of solutions (0.1-80 μg/mL) were prepared and the absorbance of these solutions was recorded at that λ max . 
Assay of commercial formulations
Fluorometholone is available in the local market with brand names FLAREX(0.1%) and flumetholon(0.1%) were purchased. Five containers were collected each marketed brand, and equivalent to 5.0g of the drug was weighed, extracted with methanol separately, sonicated and make up to volume in two different 50 mL volumetric flasks (20 µg/mL) and filtered. Further dilutions were made from this stock solution with methanol and Octane 1-sulfonic acid buffer for method A and B and analyzed according to the recommended procedure.
Precision and accuracy
The precision study was done by recording the absorbance of six replicates (20 μg/mL) for method A and B and the % RSD was calculated. Accuracy was evaluated by the recovery studies by the addition of 80%, 100% and 120% of pure drug solution to the pre-analysed formulation solution. For the present study FML drug solution extracted from the formulation was taken and 80%, 100% and 120% of pure drug solution (i.e. 8, 10 and 12 μg/mL) were added to the 10 μg/mL and the % RSD was calculated.
Results and Discussion
The optical characteristics of the proposed methods were shown in Table 1 . Beer's law was obeyed in the concentration range of 0.1-80 μg/mL and 0.1-80 μg/mL for the methods A and B respectively. The linear regression equations were found to be Y = 0.040x + 0.005 and Y = 0.040x -0.013 for method A and B respectively with correlation coefficient 0.9998 and 0.9996 respectively for both methods.
The % RSD values for precision and accuracy studies of both the methods were found to be (RSD <2%) indicating that the methods are more precise and accurate. The percentage recovery was found to be 99.65-99.12 and 99.59-100.40 for method A and B respectively ( Table 2 ). The proposed methods can be applied successfully for the determination of Fluorometholone in pharmaceutical formulations. 
Conclusion
The present methods can be employed for the determination of fluorometholone in pharmaceutical formulations successfully and there is no interference of excipients during the study.
